Cargando…

Chimeric antigen receptor-T cells immunotherapy for targeting breast cancer

Redirected chimeric antigen receptor (CAR) T-cells can recognize and eradicate cancer cells in a major histocompatibility complex independent manner. Genetic engineering of T cells through CAR expression has yielded great results in the treatment of hematological malignancies compared with solid tum...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rahimmanesh, Ilnaz, Khanahmad, Hossein
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2021
Materias:	Mini Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407156/ https://www.ncbi.nlm.nih.gov/pubmed/34522192 http://dx.doi.org/10.4103/1735-5362.323911

Ejemplares similares

Identification of Significant Genes and Pathways Associated with Tenascin-C in Cancer Progression by Bioinformatics Analysis
por: Rahimmanesh, Ilnaz, et al.
Publicado: (2022)

Harnessing NK cells for cancer immunotherapy: immune checkpoint receptors and chimeric antigen receptors
por: Kim, Nayoung, et al.
Publicado: (2021)

The challenging nature of primary T lymphocytes for transfection: Effect of protamine sulfate on the transfection efficiency of chemical transfection reagents
por: Rahimmanesh, Ilnaz, et al.
Publicado: (2020)

Conceptual Framework for SARS-CoV-2–Related Lymphopenia
por: Rahimmanesh, Ilnaz, et al.
Publicado: (2022)

The possible role of glucose-6-phosphate dehydrogenase deficiency in COVID-19 global prevalence and distribution
por: Khanahmad, Negar, et al.
Publicado: (2020)

Novel chimeric antigen receptor T cells based on T-cell receptor-like antibodies
por: Zhao, Qi
Publicado: (2019)

Enhanced in vivo anti-tumor efficacy of whole tumor lysate in combination with whole tumor cell-specific polyclonal antibody
por: Rahimmanesh, Ilnaz, et al.
Publicado: (2023)

Optimization of Culture Media for Ex vivo T-Cell Expansion for Adoptive T-Cell Therapy
por: Rahimmanesh, Ilnaz, et al.
Publicado: (2022)

Chimeric antigen receptor T-cell immunotherapy in breast cancer: development and challenges
por: Toulouie, Sara, et al.
Publicado: (2021)

Suicide Gene Therapy to Increase the Safety of Chimeric Antigen Receptor-Redirected T Lymphocytes
por: Casucci, Monica, et al.
Publicado: (2011)

Chimeric Antigen Receptor-Engineered T Cells for Immunotherapy of Cancer
por: Cartellieri, Marc, et al.
Publicado: (2010)

Chimeric antigen receptor T cell: A cancer immunotherapy
por: Singh, Surjit, et al.
Publicado: (2022)

Producing Soluble Human Programmed Cell Death Protein-1: A Natural Supporter for CD4+T Cell Cytotoxicity and Tumor Cells Apoptosis
por: Mohammadzadeh, Samane, et al.
Publicado: (2019)

Phage based vaccine: A novel strategy in prevention and treatment
por: Mohammad Hasani, Sharareh, et al.
Publicado: (2023)

Chimeric Antigen Receptor T-Cells (CAR T-Cells) for Cancer Immunotherapy – Moving Target for Industry?
por: Salmikangas, Paula, et al.
Publicado: (2018)

Chimeric antigen receptor-engineered T cells for cancer immunotherapy: progress and challenges
por: Han, Ethan Q, et al.
Publicado: (2013)

Chimeric antigen receptor-engineered natural killer cells for cancer immunotherapy
por: Yilmaz, Ahmet, et al.
Publicado: (2020)

Crosstalk of Transcriptional Regulators of Adaptive Immune System and microRNAs: An Insight into Differentiation and Development
por: Boshtam, Maryam, et al.
Publicado: (2023)

Chimeric antigen receptor T cell targeting B cell maturation antigen immunotherapy is promising for multiple myeloma
por: Ma, Tiantian, et al.
Publicado: (2019)

Nanoparticle-Based Chimeric Antigen Receptor Therapy for Cancer Immunotherapy
por: Shin, Seungyong, et al.
Publicado: (2023)

A new insight in chimeric antigen receptor-engineered T cells for cancer immunotherapy
por: Zhang, Erhao, et al.
Publicado: (2017)

Investigating chimeric antigen receptor T cell therapy and the potential for cancer immunotherapy (Review)
por: Poojary, Rayansh, et al.
Publicado: (2023)

Multi-antigen-targeted chimeric antigen receptor T cells for cancer therapy
por: Han, Xiao, et al.
Publicado: (2019)

Construction and characterization of human embryonic kidney-(HEK)-293T cell overexpressing truncated α4 integrin
por: Fatahi, Azam, et al.
Publicado: (2018)

Immunotherapy of Neuroendocrine Neoplasms: Any Role for the Chimeric Antigen Receptor T Cells?
por: Fanciulli, Giuseppe, et al.
Publicado: (2022)

Immunotherapy of Malignant Disease Using Chimeric Antigen Receptor Engrafted T Cells
por: Maher, John
Publicado: (2012)

The Molecular Basis of COVID-19 Pathogenesis, Conventional and Nanomedicine Therapy
por: Kouhpayeh, Shirin, et al.
Publicado: (2021)

T Cell Engaging Immunotherapies, Highlighting Chimeric Antigen Receptor (CAR) T Cell Therapy
por: De Bousser, Elien, et al.
Publicado: (2021)

Insights gained from single-cell analysis of chimeric antigen receptor T-cell immunotherapy in cancer
por: Tang, Lu, et al.
Publicado: (2023)

Chimeric antigen receptor for adoptive immunotherapy of cancer: latest research and future prospects
por: Shi, Huan, et al.
Publicado: (2014)

The New Frontier of Immunotherapy: Chimeric Antigen Receptor T (CAR-T) Cell and Macrophage (CAR-M) Therapy against Breast Cancer
por: Schepisi, Giuseppe, et al.
Publicado: (2023)

Display of human and rabbit monocyte chemoattractant protein-1 on human embryonic kidney 293T cell surface
por: Boshtam, Maryam, et al.
Publicado: (2018)

Engineering Metabolism of Chimeric Antigen Receptor (CAR) Cells for Developing Efficient Immunotherapies
por: Mangal, Joslyn L., et al.
Publicado: (2021)

Optimizing Manufacturing Protocols of Chimeric Antigen Receptor T Cells for Improved Anticancer Immunotherapy
por: Stock, Sophia, et al.
Publicado: (2019)

Chimeric antigen receptor natural killer cells: a promising antitumor immunotherapy
por: Wang, Yan, et al.
Publicado: (2023)

Innovations in cancer immunotherapy: chimeric antigen receptor T-cell therapy (CAR-T)
por: Brown, Kevin, et al.
Publicado: (2021)

Chimeric Antigen Receptor Expressing Natural Killer Cells for the Immunotherapy of Cancer
por: Mehta, Rohtesh S., et al.
Publicado: (2018)

Preclinical evaluation of chimeric antigen receptor T cells targeting the carcinoembryonic antigen as a potential immunotherapy for gallbladder cancer
por: Lopez, Ernesto, et al.
Publicado: (2023)

Chimeric antigen receptor-engineered NK cells: new weapons of cancer immunotherapy with great potential
por: Wang, Xiao, et al.
Publicado: (2022)

A Versatile Safeguard for Chimeric Antigen Receptor T-Cell Immunotherapies
por: Valton, Julien, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ua3kbp39c8ntebrun129rud4fh